71 related articles for article (PubMed ID: 8373235)
1. [Portal blood levels of 5-FU administered intraperitoneally].
Kakizaki K; Teshima S; Yamauchi H
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1631-3. PubMed ID: 8373235
[TBL] [Abstract][Full Text] [Related]
2. [Portal blood levels of mitomycin C after intraperitoneal administration].
Yamada Y; Kakizaki K; Yamauchi H
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1713-5. PubMed ID: 1356322
[TBL] [Abstract][Full Text] [Related]
3. [Distribution of 5-FU in rat plasma and liver tissue after local 5-FU infusion].
Zheng JL; Liang LJ; Hu WJ; Shen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):823-7. PubMed ID: 18504211
[TBL] [Abstract][Full Text] [Related]
4. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
[TBL] [Abstract][Full Text] [Related]
5. Effect of carcinomatosis and intraperitoneal 5-fluorouracil on peritoneal blood flow modulated by vasopressin in the rat as measured with the 133Xe-clearance technique.
Oman M; Tölli J; Naredi P; Hafström LO
Cancer Chemother Pharmacol; 2004 Sep; 54(3):213-8. PubMed ID: 15138707
[TBL] [Abstract][Full Text] [Related]
6. [Concentration of mitomycin C in portal blood and peripheral blood after intra venous, intraperitoneal or intrapelvic administration].
Sato Y; Ohtsuka K; Ono K
Gan To Kagaku Ryoho; 1993 Jan; 20(1):131-6. PubMed ID: 8422177
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic study of postoperative peritoneal infusion with large bulk heated hypotonic 5-fluorouracil fluid for prevention of recurrence and hepatic metastasis of gastric cancer].
Lin AD; Sun HY; Qu MW; Wang FJ; Wang JY; Li ZJ
Ai Zheng; 2002 Apr; 21(4):424-9. PubMed ID: 12452026
[TBL] [Abstract][Full Text] [Related]
8. [Portal blood levels of mitomycin C after intraperitoneal administration].
Kakizaki K; Yamada Y; Yamauchi H
Gan To Kagaku Ryoho; 1992 Jun; 19(6):913-5. PubMed ID: 1605670
[No Abstract] [Full Text] [Related]
9. [Pharmacological study on levofolinate in intraperitoneal leucovorin-5-FU chemotherapy].
Maruyama M; Ebuchi M; Nagahama T; Takashima I; Hasegawa K; Ochiai T; Natsui S
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2199-201. PubMed ID: 12484036
[TBL] [Abstract][Full Text] [Related]
10. A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity.
Bocci G; Barbara C; Vannozzi F; Di Paolo A; Melosi A; Barsanti G; Allegrini G; Falcone A; Del Tacca M; Danesi R
Clin Pharmacol Ther; 2006 Oct; 80(4):384-95. PubMed ID: 17015056
[TBL] [Abstract][Full Text] [Related]
11. [Experimental study on 5-FU intraperitoneal injection for liver metastasis].
Kawahara H; Hirai K; Aoki T
Gan To Kagaku Ryoho; 1998 May; 25(6):881-5. PubMed ID: 9617327
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients.
Bocci G; Danesi R; Di Paolo AD; Innocenti F; Allegrini G; Falcone A; Melosi A; Battistoni M; Barsanti G; Conte PF; Del Tacca M
Clin Cancer Res; 2000 Aug; 6(8):3032-7. PubMed ID: 10955781
[TBL] [Abstract][Full Text] [Related]
14. [Experimental pharmacokinetic studies of carboplatin intraperitoneal chemotherapy].
Wang J; Chen JQ
Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):196-8. PubMed ID: 7956698
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of 5-fluorouracil concentration in peripheral blood and side effects in continuous hepatic arterial infusion chemotherapy for patients with unresectable liver cancer].
Fujii K; Nakashima K; Ohno T; Anai H
Gan To Kagaku Ryoho; 1997 Sep; 24(12):1835-7. PubMed ID: 9382545
[TBL] [Abstract][Full Text] [Related]
16. [Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome].
Li Y; Liu BW; DU WL; Song ZC; Zhao Q; Fan LQ; Yang JQ; Li QJ; Wang MX; Jiao ZK; Zhang ZD
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):638-40. PubMed ID: 15634532
[TBL] [Abstract][Full Text] [Related]
17. [A case of unresectable gastric cancer responding to combined therapy with intraperitoneal cisplatinum administration and continuous intravenous infusion of 5-fluorouracil].
Kokufu I; Fukuda I; Miyake Y; Kishimoto S
Gan To Kagaku Ryoho; 1995 Dec; 22(14):2107-9. PubMed ID: 8607623
[TBL] [Abstract][Full Text] [Related]
18. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 5-fluorouracil pharmacokinetics in whole blood, plasma, and red blood cells in patients with colorectal cancer.
Wattanatorn W; McLeod HL; Macklon F; Reid M; Kendle KE; Cassidy J
Pharmacotherapy; 1997; 17(5):881-6. PubMed ID: 9324177
[TBL] [Abstract][Full Text] [Related]
20. Treatment of non-resectable pancreatic cancer with intraperitoneal 5-FU and leucovorin IV.
Oman M; Blind PJ; Naredi P; Gustavsson B; Hafström LO
Eur J Surg Oncol; 2001 Aug; 27(5):477-81. PubMed ID: 11504519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
